Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

18

Revenue 2017

Epclusa

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Epclusa was produced by Gilead Sciences.

Gilead launches European hep C awareness drive

Gilead launches European hep C awareness drive New drugs, such as Gilead's recently approved pan-genotypic chronic HCV treatment Epclusa, are now able to offer a cure for more than 90% of people living with hepatitis C.

Gilead’s hepatitis C sales start to slide – the question is how quickly?

Gilead’s hepatitis C sales start to slide – the question is how quickly? Gilead is looking to the future with new universal two-drug regimen Epclusa (sofosbuvir/velpatasvir) - which started to build inventory in the quarter after approval in the US last month - as

Gilead’s universal hep C therapy Epclusa approved in EU

Gilead’s universal hep C therapy Epclusa approved in EU European nod for first pan-genotypic treatment follows recent FDA licensing. Gilead's pan-genotypic hepatitis C virus (HCV) treatment Epclusa has been granted marketing authorisation following an accelerated review procedure ... He added that the pharma

FDA approves Gilead's 'universal' hep C combination Epclusa

FDA approves Gilead's 'universal' hep C combination Epclusa Adds a third Sovaldi-based treatment to the firm’s portfolio. US regulators have approved Gilead's Epclusa (sofosbuvir/velpatasvir) to treat adult patients with chronic hepatitis C virus (HCV) both ... Epclusa joins Sovaldi and Harvoni

Gilead, Merck get CHMP backing for new hep C combinations

Gilead, Merck get CHMP backing for new hep C combinations Approval of Epclusa and Zepatier will see the pan-genotypic drugs compete for market share. ... Epclusa and Zepatier belong to a new generation of medicines for chronic HCV infection, direct-acting antivirals, that give high rates of cure of HCV infection

[ Previous 5 results ] 1 2 3

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

A snapshot of… Exscientia
...
Patients are ready for virtual clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...
Keep your audiences close
How getting up close and personal with target audiences can fuel creativity...

Infographics